-
August 28, 2017PREVIEW
Use of canagliflozin (Invokana—Janssen) in patients with type 2 diabetes who had established cardiovascular (CV) disease or CV risk factors resulted in a 14% reduction in the composite endpoint of...
-
August 8, 2017PREVIEW
A new position statement released by the North American Menopause Society on hormone replacement therapy (HRT) noted that the benefits of HRT may outweigh the risks for management of vasomotor...
-
July 17, 2017PREVIEW
The American College of Rheumatology (ACR) released updated recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis in adults, children, and special populations....
-
June 20, 2017PREVIEW
Use of pioglitazone, an oral thiazolidinedione antihyperglycemic agent, was associated with an increased risk of bone fractures in insulin-resistant, nondiabetic patients with a recent history of...
-
June 12, 2017PREVIEW
The safety and beneficial effects of osteoporosis medications on bone mineral density (BMD) and fracture risk in patients with chronic kidney disease (CKD) are unclear, according to results of a...
Pages
